Arete Wealth Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
17,128
-1,426
-8% -$107K 0.09% 204
2025
Q4
$1.47M Buy
18,554
+1,504
+9% +$119K 0.09% 221
2025
Q3
$1.4M Buy
17,050
+628
+4% +$49.4K 0.09% 212
2025
Q2
$1.32M Buy
16,422
+8
+0% +$617 0.09% 214
2025
Q1
$1.25M Buy
16,414
+1,642
+11% +$137K 0.1% 219
2024
Q4
$1.21M Buy
14,772
+1,123
+8% +$93.4K 0.09% 225
2024
Q3
$1.12M Sell
13,649
-218
-2% -$16.3K 0.1% 208
2024
Q2
$972K Sell
13,867
-757
-5% -$54K 0.08% 240
2024
Q1
$1.08M Sell
14,624
-979
-6% -$68.2K 0.1% 198
2023
Q4
$1.01M Sell
15,603
-259
-2% -$16.2K 0.08% 250
2023
Q3
$990K Buy
15,862
+793
+5% +$49.4K 0.17% 130
2023
Q2
$852K Sell
15,069
-1,228
-8% -$68.1K 0.08% 240
2023
Q1
$944K Buy
16,297
+1,666
+11% +$112K 0.08% 224
2022
Q4
$1.06B Buy
14,631
+2,873
+24% +$206K 0.09% 188
2022
Q3
$715K Buy
11,758
+1,531
+15% +$97.8K 0.07% 233
2022
Q2
$642K Buy
10,227
+1,415
+16% +$93.7K 0.06% 202
2022
Q1
$619K Buy
8,812
+480
+6% +$32.5K 0.05% 246
2021
Q4
$527K Buy
8,332
+1,463
+21% +$91.8K 0.04% 277
2021
Q3
$424K Buy
6,869
+925
+16% +$55.7K 0.05% 280
2021
Q2
$344K Buy
5,944
+652
+12% +$41.3K 0.05% 247
2021
Q1
$322K Buy
5,292
+897
+20% +$49.5K 0.04% 307
2020
Q4
$206K Buy
+4,395
New +$190K 0.03% 377
2018
Q1
Sell
-11,681
Closed -$591K 340
2017
Q4
$591K Sell
11,681
-303
-3% -$16K 0.19% 145
2017
Q3
$623K Sell
11,984
-255
-2% -$12.4K 0.25% 127
2017
Q2
$599K Sell
12,239
-519
-4% -$24.1K 0.27% 102
2017
Q1
$601K Buy
12,758
+2,432
+24% +$116K 0.26% 84
2016
Q4
$496K Buy
+10,326
New +$474K 0.23% 92

Other funds holding MET

Arete Wealth Advisors's MET Position: Q1 2026 in Review

Arete Wealth Advisors reduced its MetLife (MET) stake by 7.7% in Q1 2026, selling an estimated $107K and leaving 17,128 shares worth $1.21M. The position accounts for 0.09% of the portfolio, ranked #204.

Arete Wealth Advisors first reported a position in MET in Q4 2016 and has held it in 27 quarters since. The position peaked at $1.06B in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Arete Wealth Advisors held 17,128 shares of MetLife worth $1.21M as of Q1 2026.
  • Arete Wealth Advisors sold 1,426 MetLife shares in Q1 2026, an estimated $107K.
  • MetLife made up 0.09% of Arete Wealth Advisors's portfolio in Q1 2026, its #204 holding.
  • Arete Wealth Advisors first reported a position in MetLife in Q4 2016 and has held it in 27 quarters since.
  • Arete Wealth Advisors's MetLife position peaked at $1.06B in Q4 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.